Anthony Y Sun Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

Anthony Y Sun is President & CEO of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 1.18 Million shares of ZNTL, which is worth approximately $4.66 Million. The most recent transaction as insider was on Apr 05, 2022, when has been sold 10,471 shares (Common Stock) at a price of $51.73 per share, resulting in proceeds of $541,665. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.18M

0% 3M change

0% 12M change

Total Value Held $4.66 Million

ANTHONY Y SUN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 05 2022	SELL Open market or private sale	$541,665 $51.73 p/Share	10,471 Reduced 0.88%	1,175,589 Common Stock
Apr 04 2022	SELL Open market or private sale	$507,844 $48.5 p/Share	10,471 Reduced 0.88%	1,186,060 Common Stock
Mar 02 2022	SELL Open market or private sale	$528,890 $50.51 p/Share	10,471 Reduced 0.87%	1,196,531 Common Stock
Mar 01 2022	SELL Open market or private sale	$522,503 $49.9 p/Share	10,471 Reduced 0.86%	1,207,002 Common Stock
Feb 14 2022	SELL Open market or private sale	$238,827 $50.46 p/Share	4,733 Reduced 0.39%	1,217,473 Common Stock
Feb 10 2022	BUY Grant, award, or other acquisition	-	50,431 Added 3.96%	1,222,206 Common Stock
Feb 02 2022	SELL Open market or private sale	$608,156 $58.08 p/Share	10,471 Reduced 0.89%	1,171,775 Common Stock
Feb 01 2022	SELL Open market or private sale	$608,260 $58.09 p/Share	10,471 Reduced 0.88%	1,182,246 Common Stock
Jan 04 2022	SELL Open market or private sale	$828,361 $79.11 p/Share	10,471 Reduced 0.87%	1,192,717 Common Stock
Jan 03 2022	SELL Open market or private sale	$846,476 $80.84 p/Share	10,471 Reduced 0.86%	1,203,188 Common Stock
Dec 16 2021	SELL Bona fide gift	-	15,000 Reduced 1.22%	1,213,659 Common Stock
Dec 02 2021	SELL Open market or private sale	$794,644 $75.89 p/Share	10,471 Reduced 0.94%	1,103,659 Common Stock
Dec 01 2021	SELL Open market or private sale	$811,817 $77.53 p/Share	10,471 Reduced 0.93%	1,114,130 Common Stock
Nov 26 2021	SELL Bona fide gift	-	125,000 Reduced 10.0%	1,124,601 Common Stock
Nov 02 2021	SELL Open market or private sale	$840,507 $80.27 p/Share	10,471 Reduced 0.83%	1,249,601 Common Stock
Nov 01 2021	SELL Open market or private sale	$858,308 $81.97 p/Share	10,471 Reduced 0.82%	1,260,072 Common Stock
Oct 04 2021	SELL Open market or private sale	$1,783,741 $66.56 p/Share	26,799 Reduced 2.07%	1,270,543 Common Stock
Sep 01 2021	SELL Open market or private sale	$1,817,437 $67.83 p/Share	26,794 Reduced 2.02%	1,297,342 Common Stock
Aug 03 2021	SELL Open market or private sale	$394,317 $50.69 p/Share	7,779 Reduced 0.58%	1,324,136 Common Stock
Aug 02 2021	SELL Open market or private sale	$982,695 $51.68 p/Share	19,015 Reduced 1.41%	1,331,915 Common Stock
Jul 07 2021	SELL Open market or private sale	$837,500 $47.04 p/Share	17,804 Reduced 1.3%	1,350,930 Common Stock
Jul 06 2021	SELL Open market or private sale	$1,191,892 $47.59 p/Share	25,045 Reduced 1.8%	1,368,734 Common Stock
Jul 01 2021	SELL Open market or private sale	$1,385,518 $51.71 p/Share	26,794 Reduced 1.89%	1,393,779 Common Stock
Jun 01 2021	SELL Open market or private sale	$1,455,986 $54.34 p/Share	26,794 Reduced 1.85%	1,420,573 Common Stock
May 03 2021	SELL Open market or private sale	$1,570,932 $58.63 p/Share	26,794 Reduced 1.82%	1,447,367 Common Stock

Also insider at

EYEN

EYENOVIA, INC. Healthcare

AYS

Anthony Y Sun

President & CEO

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Value

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Track Activities on ZNTL

Account